Difesa Capital Management’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,500
Closed -$3K 319
2022
Q3
$3K Hold
37,500
﹤0.01% 216
2022
Q2
$4K Hold
37,500
﹤0.01% 229
2022
Q1
$13K Hold
37,500
0.01% 212
2021
Q4
$20K Buy
+37,500
New +$21.4K 0.01% 200

Other funds holding EQHA.WS

Difesa Capital Management's EQHA.WS Position: Q4 2022 in Review

Difesa Capital Management sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 37,500 shares — an estimated $3K sold.

Difesa Capital Management first reported a position in EQHA.WS in Q4 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Difesa Capital Management reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Difesa Capital Management sold 37,500 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $3K.
  • Difesa Capital Management first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 4 quarters.
  • Difesa Capital Management's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $20K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Difesa Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.